AHB
Abner Herrman & Brock’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6M | Buy |
27,648
+314
| +1% | +$245K | 2.41% | 15 |
|
|
2025
Q1 | $22.6M | Buy |
27,334
+477
| +2% | +$394K | 2.88% | 10 |
|
|
2024
Q4 | $20.7M | Buy |
26,857
+349
| +1% | +$269K | 2.58% | 14 |
|
|
2024
Q3 | $23.5M | Buy |
26,508
+103
| +0.4% | +$91.3K | 2.83% | 11 |
|
|
2024
Q2 | $23.9M | Buy |
26,405
+33
| +0.1% | +$29.9K | 3.03% | 7 |
|
|
2024
Q1 | $20.5M | Buy |
26,372
+373
| +1% | +$290K | 2.56% | 13 |
|
|
2023
Q4 | $15.2M | Buy |
25,999
+17,889
| +221% | +$10.4M | 2.13% | 26 |
|
|
2023
Q3 | $4.36M | Buy |
8,110
+8
| +0.1% | +$4.3K | 0.67% | 40 |
|
|
2023
Q2 | $3.8M | Buy |
8,102
+72
| +0.9% | +$33.8K | 0.56% | 41 |
|
|
2023
Q1 | $2.76M | Sell |
8,030
-3,733
| -32% | -$1.28M | 0.42% | 48 |
|
|
2022
Q4 | $4.3M | Buy |
11,763
+3,753
| +47% | +$1.37M | 0.66% | 39 |
|
|
2022
Q3 | $2.59M | Buy |
8,010
+6,894
| +618% | +$2.23M | 0.47% | 43 |
|
|
2022
Q2 | $362K | Buy |
+1,116
| New | +$362K | 0.06% | 69 |
|
|
2016
Q4 | – | Sell |
-15,143
| Closed | -$1.22M | – | 123 |
|
|
2016
Q3 | $1.22M | Buy |
+15,143
| New | +$1.22M | 0.28% | 62 |
|